3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
2
Terminated
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Breast Neoplasms
7
Colorectal Neoplasms
2
HER2+ Breast Cancer
1
HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
1
Gastrointestinal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Advanced Breast Cancer
1
Interventions
Fluorouracil
81
Oxaliplatin
72
Leucovorin
67
Irinotecan
61
Capecitabine
58
Bevacizumab
58
Cetuximab
43
Folfox protocol
22
Drug Therapy
22
Neoadjuvant Therapy
19
HMPL-013
17
Colonoscopy
17
regorafenib
15
apatinib
11
Panitumumab
11
Chemotherapy, Adjuvant
11
trifluridine tipiracil drug combination
10
XELOX
10
Laparoscopy
10
IFL protocol
10
sintilimab
9
raltitrexed
9
Radiotherapy
9
Blood Specimen Collection
9
Surveys and Questionnaires
8
Surgical Procedures, Operative
8
tislelizumab
7
pembrolizumab
7
Endoscopic Mucosal Resection
7
Aspirin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Colorectal Neoplasms
×
Ado-Trastuzumab Emtansine
×
Clear all
NCT03418558
2018-10-31
RESCUE
Fondazione del Piemonte per l'Oncologia
Phase 2
Unknown
13 enrolled
NCT03225937
2018-10-30
HERACLES
Fondazione del Piemonte per l'Oncologia
Phase 2
Unknown
54 enrolled